Company News

Medmeme makes new senior sales appointment ACG Group appoints Richard Stedman as Group CEO Tetra Bio-Pharma appoints Bernard Fortier CEO Johnson Matthey turns 200 years old Chris Rombach joins ChargePoint aiding US expansion following multi-million-pound investment Surfachem appoints Dr Philip Wright as Strategic Business Development Manager The Royal Society announces Croonian Medallist 2018 Prof J Dressman joins Certara’s Simcyp Scientific Advisory Board Hubbard and Daikin united in commercial refrigeration TricorBraun announce new management positions Allied Minds subsidiary BridgeSat appoint Barry Matsumori CEO Cyclists Chiara Ricciardo and Riccardo Rocchi raise diabetes awareness Pharma companies still searching for answers on gender diversity Concept Life Sciences appoints Dr Andrew Clifton BioAscent appoints new CEO and plans to expand discovery services PharmaLex Group strengthens biosimilar expertise

Trending Articles

  1. Lonza appoints Hans Trees as Global Head of Communications Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
  2. MHRA scientific leader recognised in 2026 King's Birthday Honours Dr Nicola Rose receives OBE for services to science and public health
  3. Servomex appoints new Global Sales Director Servomex, international expert in gas analysis, has appointed David Jones as Global Sales Director to lead and strengthen its worldwide commercial strategy. Based in the UK head office, David brings more than three decades of experience in management and commercial leadership, along with a strong vision for Servomex at a time of rapid growth in semiconductor manufacturing, tightening emissions regulations, and rising demand for precision gas analysis
  4. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  5. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all